136 related articles for article (PubMed ID: 34880110)
1. Truly Man's Best Friend: Canine Cancers Drive Drug Repurposing in Osteosarcoma.
Weiss MC; Eulo V; Van Tine BA
Clin Cancer Res; 2022 Feb; 28(4):571-572. PubMed ID: 34880110
[TBL] [Abstract][Full Text] [Related]
2. Comparative biology of human and canine osteosarcoma.
Mueller F; Fuchs B; Kaser-Hotz B
Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of complex karyotype changes in two canine bone tumours.
Mayr B; Eschborn U; Loupal G; Schleger W
Res Vet Sci; 1991 Nov; 51(3):341-3. PubMed ID: 1780594
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological relevance of tumour grading in canine osteosarcoma.
Loukopoulos P; Robinson WF
J Comp Pathol; 2007 Jan; 136(1):65-73. PubMed ID: 17270206
[TBL] [Abstract][Full Text] [Related]
5. Effects of lycopene on proliferation and death of canine osteosarcoma cells.
Wakshlag JJ; Balkman CE
Am J Vet Res; 2010 Nov; 71(11):1362-70. PubMed ID: 21034328
[TBL] [Abstract][Full Text] [Related]
6. Effect of isolated limb perfusion with cisplatin (CDDP) on canine osteosarcoma.
Hoekstra HJ; Meutstege FJ; Oosterhuis JW; De Vries J; Schraffordt Koops H
Cancer Treat Res; 1993; 62():245-9. PubMed ID: 8096740
[No Abstract] [Full Text] [Related]
7. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
York D; Withers SS; Watson KD; Seo KW; Rebhun RB
Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
[TBL] [Abstract][Full Text] [Related]
8. Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for COX-2 in tumour initiation.
Pang LY; Gatenby EL; Kamida A; Whitelaw BA; Hupp TR; Argyle DJ
PLoS One; 2014; 9(1):e83144. PubMed ID: 24416158
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of dihydroartemisinin in canine osteosarcoma cell lines.
Hosoya K; Murahari S; Laio A; London CA; Couto CG; Kisseberth WC
Am J Vet Res; 2008 Apr; 69(4):519-26. PubMed ID: 18380584
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.
Chu S; Skidmore ZL; Kunisaki J; Walker JR; Griffith M; Griffith OL; Bryan JN
PLoS One; 2021; 16(2):e0246443. PubMed ID: 33556121
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog.
Johnson AS; Couto CG; Weghorst CM
Carcinogenesis; 1998 Jan; 19(1):213-7. PubMed ID: 9472714
[TBL] [Abstract][Full Text] [Related]
12. Current veterinary therapy in canine osteosarcoma.
Kirpensteijn J
Vet Q; 1994 Apr; 16 Suppl 1():24S-25S. PubMed ID: 7801461
[No Abstract] [Full Text] [Related]
13. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
14. The animal-dependent risk factors in canine osteosarcomas.
Sapierzyński R; Czopowicz M
Pol J Vet Sci; 2017 Mar; 20(2):293-298. PubMed ID: 28865206
[TBL] [Abstract][Full Text] [Related]
15. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma.
Alegre F; Ormonde AR; Godinez DR; Illendula A; Bushweller JH; Wittenburg LA
Vet Comp Oncol; 2020 Mar; 18(1):52-63. PubMed ID: 31381810
[TBL] [Abstract][Full Text] [Related]
16. Seeking enrolment for a new treatment for canine osteosarcoma.
Polton G; Dunning M
J Small Anim Pract; 2015 Jul; 56(7):481. PubMed ID: 26134604
[No Abstract] [Full Text] [Related]
17. In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells.
Hong SH; Kadosawa T; Nozaki K; Mochizuki M; Matsunaga S; Nishimura R; Sasaki N
Am J Vet Res; 2000 Jan; 61(1):69-73. PubMed ID: 10630782
[TBL] [Abstract][Full Text] [Related]
18. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
19. Risk-modeling of dog osteosarcoma genome scans shows individuals with Mendelian-level polygenic risk are common.
Zapata I; Moraes LE; Fiala EM; Zaldivar-Lopez S; Couto CG; Rowell JL; Alvarez CE
BMC Genomics; 2019 Mar; 20(1):226. PubMed ID: 30890123
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs.
Royals SR; Farese JP; Milner RJ; Lee-Ambrose L; van Gilder J
Am J Vet Res; 2005 Nov; 66(11):1961-7. PubMed ID: 16334957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
